Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT

作者: Sabrina Brahimi-Adouane , Jean-Baptiste Bachet , Séverine Tabone-Eglinger , Frédéric Subra , Claude Capron

DOI: 10.1016/J.MOLONC.2012.10.008

关键词: Brefeldin API3K/AKT/mTOR pathwayTyrosine kinaseMolecular biologyBiologyWild typeProtein kinase BEndoplasmic reticulumImatinib mesylateTunicamycinMolecular medicineGeneticsCancer researchGeneral Medicine

摘要: Gain of function mutations KIT are frequent in some human tumors, and sensible to tyrosine kinase inhibitors. In most oncogenic heterozygous, however vitro data activation have been obtained with hemizygous mutation. This study aimed investigate the maturation wild-type (WT) mutant (M) forms heterozygous conditions. WT two types exon 11 deletions M were expressed NIH3T3 cell lines. Membrane expression was quantified by flow cytometry. Quantification glycosylated phosphorylated AKT ERK performed western blot. Simultaneous treatment endoplasmic reticulum (ER) inhibitors, tunicamycin or brefeldin A induced a complete inhibition membrane 145 kDa form KIT. By contrast ER inhibitors alone, only partly inhibited this form. also activation-dependent phosphorylation ERK1/2. Brefeldin down regulation M, an intra-cellular accumulation 125 but not M. Heterozygous cells had glycosylation response patterns more similar than Phosphorylated reduced comparison cells, presence all Effects significantly different mutants. Differences trafficking result differences downstream signaling pathways, PI3K/AKT pathway appears be tied mature at surface.

参考文章(33)
Tohru Tsujimura, Koji Hashimoto, Hitoshi Kitayama, Hirokazu Ikeda, Hiroyuki Sugahara, Itaru Matsumura, Tsuneyasu Kaisho, Nobuyuki Terada, Yukihiko Kitamura, Yuzuru Kanakura, Activating Mutation in the Catalytic Domain of c-kit Elicits Hematopoietic Transformation by Receptor Self-Association Not at the Ligand-Induced Dimerization Site Blood. ,vol. 93, pp. 1319- 1329 ,(1999) , 10.1182/BLOOD.V93.4.1319
H Kitayama, Y Kanakura, T Furitsu, T Tsujimura, K Oritani, H Ikeda, H Sugahara, H Mitsui, Y Kanayama, Y Kitamura, Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood. ,vol. 85, pp. 790- 798 ,(1995) , 10.1182/BLOOD.V85.3.790.BLOODJOURNAL853790
P A Cassier, F Ducimetière, A Lurkin, D Ranchère-Vince, J-Y Scoazec, P-P Bringuier, A-V Decouvelaere, P Méeus, D Cellier, J-Y Blay, I Ray-Coquard, A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region British Journal of Cancer. ,vol. 103, pp. 165- 170 ,(2010) , 10.1038/SJ.BJC.6605743
Ying Yang, Sébastien Létard, Laurence Borge, Amandine Chaix, Katia Hanssens, Sophie Lopez, Marina Vita, Pascal Finetti, Daniel Birnbaum, François Bertucci, Sophie Gomez, Paulo de Sepulveda, Patrice Dubreuil, Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations Blood. ,vol. 116, pp. 1114- 1123 ,(2010) , 10.1182/BLOOD-2009-06-226027
Jerzy Lasota, Anna Jerzak vel Dobosz, Bartosz Wasag, Agnieszka Wozniak, Ewa Kraszewska, Wanda Michej, Konrad Ptaszynski, Piotr Rutkowski, Maarit Sarlomo-Rikala, Sonja E Steigen, Regine Schneider-Stock, Jerzy Stachura, Maria Chosia, Gabriel Ogun, Wlodzimierz Ruka, Janusz A Siedlecki, Markku Miettinen, Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors Laboratory Investigation. ,vol. 87, pp. 1029- 1041 ,(2007) , 10.1038/LABINVEST.3700628
Jean—franÇois Emile, Nathalie Théou, Séverine Tabone, Annie Cortez, Philippe Terrier, Marie—thérèse Chaumette, Catherine Julié, Philippe Bertheau, Anne Lavergne—slove, Jean Donadieu, Alain Barrier, Axel Le Cesne, Brigitte Debuire, Antoinette Lemoine, The Gegist, Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors Clinical Gastroenterology and Hepatology. ,vol. 2, pp. 597- 605 ,(2004) , 10.1016/S1542-3565(04)00243-5
Ronald P. DeMatteo, Jason S. Gold, Lisa Saran, Mithat Gönen, Kui Hin Liau, Robert G. Maki, Samuel Singer, Peter Besmer, Murray F. Brennan, Cristina R. Antonescu, Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer. ,vol. 112, pp. 608- 615 ,(2008) , 10.1002/CNCR.23199
Linda Gibbs, Laurence Legeai-Mallet, FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. ,vol. 1773, pp. 502- 512 ,(2007) , 10.1016/J.BBAMCR.2006.12.010
B. Imperiali, K. W. Rickert, Conformational implications of asparagine-linked glycosylation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 97- 101 ,(1995) , 10.1073/PNAS.92.1.97
Karl Staser, Feng-Chun Yang, D. Wade Clapp, Mast cells and the neurofibroma microenvironment. Blood. ,vol. 116, pp. 157- 164 ,(2010) , 10.1182/BLOOD-2009-09-242875